Form 10-Q MUSTANG BIO, INC. For: Jun 30

Go back to Form 10-Q MUSTANG BIO, INC. For: Jun 30

Fortress Biotech (FBIO) PT Raised to $13 at Roth/MKM

August 14, 2024 5:06 AM EDT

Roth/MKM analyst Jason Whittes raised the price target on Fortress Biotech (NASDAQ: FBIO) to $13.00 (from $10.00) while maintaining a Buy rating.

The analyst comments "FBIO reported 2Q24 revenues down 14.4% to $14.9 million vs. consensus of $14.8 million and our estimate of $14.0 million. EPS was ($0.73) vs.... More